Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

557 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Interobserver variability in target volume delineation of hepatocellular carcinoma : An analysis of the working group "Stereotactic Radiotherapy" of the German Society for Radiation Oncology (DEGRO).
Gkika E, Tanadini-Lang S, Kirste S, Holzner PA, Neeff HP, Rischke HC, Reese T, Lohaus F, Duma MN, Dieckmann K, Semrau R, Stockinger M, Imhoff D, Kremers N, Häfner MF, Andratschke N, Nestle U, Grosu AL, Guckenberger M, Brunner TB. Gkika E, et al. Among authors: dieckmann k. Strahlenther Onkol. 2017 Oct;193(10):823-830. doi: 10.1007/s00066-017-1177-y. Epub 2017 Jul 10. Strahlenther Onkol. 2017. PMID: 28695316 English.
Safety and efficacy of stereotactic body radiotherapy for stage 1 non-small-cell lung cancer in routine clinical practice: a patterns-of-care and outcome analysis.
Guckenberger M, Allgäuer M, Appold S, Dieckmann K, Ernst I, Ganswindt U, Holy R, Nestle U, Nevinny-Stickel M, Semrau S, Sterzing F, Wittig A, Andratschke N. Guckenberger M, et al. Among authors: dieckmann k. J Thorac Oncol. 2013 Aug;8(8):1050-8. doi: 10.1097/JTO.0b013e318293dc45. J Thorac Oncol. 2013. PMID: 23817193 Free article.
Applicability of the linear-quadratic formalism for modeling local tumor control probability in high dose per fraction stereotactic body radiotherapy for early stage non-small cell lung cancer.
Guckenberger M, Klement RJ, Allgäuer M, Appold S, Dieckmann K, Ernst I, Ganswindt U, Holy R, Nestle U, Nevinny-Stickel M, Semrau S, Sterzing F, Wittig A, Andratschke N, Flentje M. Guckenberger M, et al. Among authors: dieckmann k. Radiother Oncol. 2013 Oct;109(1):13-20. doi: 10.1016/j.radonc.2013.09.005. Epub 2013 Oct 30. Radiother Oncol. 2013. PMID: 24183066
Support vector machine-based prediction of local tumor control after stereotactic body radiation therapy for early-stage non-small cell lung cancer.
Klement RJ, Allgäuer M, Appold S, Dieckmann K, Ernst I, Ganswindt U, Holy R, Nestle U, Nevinny-Stickel M, Semrau S, Sterzing F, Wittig A, Andratschke N, Guckenberger M. Klement RJ, et al. Among authors: dieckmann k. Int J Radiat Oncol Biol Phys. 2014 Mar 1;88(3):732-8. doi: 10.1016/j.ijrobp.2013.11.216. Epub 2014 Jan 7. Int J Radiat Oncol Biol Phys. 2014. PMID: 24411630
Prognostic significance of Ki67 proliferation index, HIF1 alpha index and microvascular density in patients with non-small cell lung cancer brain metastases.
Berghoff AS, Ilhan-Mutlu A, Wöhrer A, Hackl M, Widhalm G, Hainfellner JA, Dieckmann K, Melchardt T, Dome B, Heinzl H, Birner P, Preusser M. Berghoff AS, et al. Among authors: dieckmann k. Strahlenther Onkol. 2014 Jul;190(7):676-85. doi: 10.1007/s00066-014-0639-8. Epub 2014 Feb 28. Strahlenther Onkol. 2014. PMID: 24577133
Novel radiotherapy techniques for involved-field and involved-node treatment of mediastinal Hodgkin lymphoma: when should they be considered and which questions remain open?
Lohr F, Georg D, Cozzi L, Eich HT, Weber DC, Koeck J, Knäusl B, Dieckmann K, Abo-Madyan Y, Fiandra C, Mueller RP, Engert A, Ricardi U. Lohr F, et al. Among authors: dieckmann k. Strahlenther Onkol. 2014 Oct;190(10):864-6, 868-71. doi: 10.1007/s00066-014-0719-9. Epub 2014 Sep 11. Strahlenther Onkol. 2014. PMID: 25209551 Free article. Review.
557 results